Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 V617F and JAK2 exon 12 allele burden disappearance during the follow-up of two patients
- 27 November 2015
- journal article
- case report
- Published by Springer Nature in Annals of Hematology
- Vol. 95 (3) , 529-531
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Spontaneous regression of essential thrombocythemia with MPL mutation on menopauseInternational Journal of Hematology, 2014
- Coexistence of Myeloproliferative Neoplasm and Plasma-Cell DyscrasiaClinical Lymphoma Myeloma and Leukemia, 2014
- Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivoOncogene, 2013
- The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case reportJournal of Medical Case Reports, 2013
- High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutationBone Marrow Transplantation, 2013
- No Evidence for JAK2V617F Mutation in Monoclonal B Cells in 2 Patients with Polycythaemia Vera and Concurrent Monoclonal B Cell DisorderActa Haematologica, 2012
- The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experienceAmerican Journal of Hematology, 2011
- Acquired Thrombophilia in Pregnancy: Essential ThrombocythemiaSeminars in Thrombosis and Hemostasis, 2003
- ROLE OF INTERLEUKIN‐6 IN THE PATHOGENESIS OF MULTIPLE MYELOMACell Biology International, 2000